Effects of troglitazone in hispanic patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Effects of troglitazone in hispanic patients with type 2 diabetes mellitus

Published:1999-09 Issue:9 Volume:60 Page:494-501
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Mavandadi Azita,Gong William C.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Troglitazone: A new and unique oral anti-diabetic agent for the treatment of type II diabetes and the insulin resistance syndrome;Edelman;Clin Diabetes,1997

2. Troglitazone: A new antihyperglycemic agent;Speerhas;Clevel Clin J Med.,1997

3. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease;Defronzo;Diabetes Care.,1991

4. Are risk factors for conversion to NIDDM similar in high and low risk populations?;Haffner;Diabetologia.,1997

5. Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites;Haffner;Diabetes Care.,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione;Diabetes, Obesity and Metabolism;2006-09

2. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione;Diabetes, Obesity and Metabolism;2006-03-10

3. Effects of pioglitazone on diabetes-related outcomes in Hispanic patients;American Journal of Health-System Pharmacy;2003-03-01